Paul B. Fisher, MPh, PhD, FNAI, Professor and Chairman, Department of Human and Molecular Genetics, Director, VCU Institute of Molecular Medicine Thelma Newmeyer Corman Chair in Cancer Research in the VCU Massey Cancer Center, VCU, School of Medicine, Richmond, VA, and Emeritus Professor, Columbia University, College of Physicians & Surgeons, New York, NY. Dr. Fisher is among the top 10% of NIH funded investigators over the past 35-years, published approximately 625 papers and reviews, and has 55 issued patents. He pioneered novel gene/discovery approaches (subtraction hybridization), developed innovative therapeutic approaches (Cancer Terminator Viruses), presented numerous named and distinguished lectures, founded several start-up companies, was Virginia Outstanding Scientist of 2014 and elected to the National Academy of Inventors in 2018. Dr. Fisher is a prominent nationally and internationally recognized cancer research scientist focusing on understanding the molecular and biochemical basis of cancer development and progression to metastasis and using this garnered information to develop innovative approaches for diagnosing and treating cancer. He discovered and patented novel genes and gene promoters relevant to cancer growth control, differentiation and apoptosis. His discoveries include the first cloning of p21 (CDK inhibitor), human polynucleotide phosphorylase, mda-9/syntenin (a pro-metastatic gene), mda-5 and mda-7/IL-24, which has shown promising clinical activity in Phase I/II clinical trials in patients with advanced cancers. Dr. Fisher alsohas a documented track record as a successful seasoned entrepreneur. He was Founder and Director of GenQuest Incorporated, a functional genomics company, which merged with Corixa Corporation in 1998, traded on NASDAQ and was acquired by GlaxoSmithKline in 2006. He discovered the cancer-specific PEG-Prom, which is the core technology of Cancer Targeting Systems (CTS, Inc.), a Virginia/Maryland-based company (at Johns Hopkins Medical Center) focusing on imaging and therapy ("theranostics") of metastatic cancer (2014) by Drs. Fisher and Martin G. Pomper. He co-founded InVaMet Therapeutics (IVMT) and InterLeukin Combinatorial Therapies (ILCT) with Dr. Webster K. Cavenee (UCSD) (2017/2018).

David D. Limbrick Jr., MD, PhD is Professor and Chair of Neurosurgery at Virginia Commonwealth University School of Medicine and VCU Health. He holds the James W. and Francis G. McGlothlin Chair in Neurosurgery. His clinical focus is on pediatric brain tumors and innovative surgical methods for brain tumors as they occur across the lifespan. Dr. Limbrick is internationally regarded for his expertise in neuro-endoscopic treatment of intracranial disease and for treating complex disorders of the craniovertebral junction, including the Chiari malformations. He has received the Public Service Citation from the American Association of Neurological Surgeons and Congress of Neurological Surgeons for international neurosurgical relief work, the Humanism in Medicine Award from Washington University School of Medicine, and the Innovator Award from the Hydrocephalus Association. Dr. Limbrick's primary research focus is on cerebrospinal fluid disorders, where he is active in basic, clinical, and translational research. He serves as Principal Investigator for two major multicenter randomized controlled trials: Posterior Fossa Decompression with or without Duraplasty for Chiari Type I Malformation and Syringomyelia and Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants. He is Chair of Biospecimens and Neuro-Imaging for the Hydrocephalus Clinical Research Network and has been the Principal Investigator for the Park-Reeves Syringomyelia Research Consortium since its inception. His research has been continuously funded by NIH, PCORI, and other federal agencies since he joined the faculty in 2008. Most recently, he was the recipient of a program project award (PPG) and an R25 educational grant with a long-term goal of increasing the diversity of the pediatric neurosciences workforce. Dr. Limbrick has authored more than 270 peer-reviewed journal articles and 15 book chapters and has given more than 150 national/international presentations. He has edited two books and serves on the Editorial Board of Journal of Neurosurgery: Pediatrics, Fluids and Barriers of the CNS, and Neurosurgery Practice, where he is the section editor for Pediatric Neurosurgery. He serves as Treasurer of the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Joint Section for Pediatric Neurosurgery, Secretary of the Accreditation Council for Pediatric Neurosurgery Fellowships (ACPNF), and on the Executive Committee of the American Society of Pediatric Neurosurgeons (ASPN). He is a member of the Academy of Neurological Surgeons and the Society of Neurological Surgeons and serves on the National Advisory Committee of the Neurosurgeon Research Career Development Program (NRCDP). Nationally, he serves on the boards of Cure Hydrocephalus, Bobby Jones Chiari & Syringomyelia Foundation, Rudy Schulte Institute, and the Hydrocephalus Association, including the HA Washington Advocacy Committee. Edit

Mohamed S. Abdelbaki is Associate Professor of Pediatrics, Hematology and Oncology at Washington University School of Medicine, MO, USA.

« A propos de ce titre » peut appartenir à une autre édition de cet ouvrage.

preigu

Osnabrück, Allemagne

Vendeur avec une évaluation de 5 étoiles

Vendeur AbeBooks depuis 5 août 2024

Frais d'expédition de Allemagne vers Etats-Unis

Article	60 à 60 jours ouvrés	60 à 60 jours ouvrés
Premier article	EUR 70,00	EUR 70,00

Les délais de livraison sont fixés par les vendeurs et varient en fonction du transporteur et du lieu. Les commandes transitant par les douanes peuvent être retardées et les acheteurs sont responsables de tous les droits ou frais associés. Les vendeurs peuvent vous contacter au sujet de frais supplémentaires afin de couvrir toute augmentation des coûts d'expédition de vos articles.

Modes de paiement

Paypal

Description de la boutique

preigu betreibt einen Onlineversandhandel mit über 1 Mio. Produkten in verschiedenen Sortimenten. Das Kernsortiment besteht aus Büchern, Medien und Spielwaren. Ein gelungenes Einkaufserlebnis ist das Ziel einer jeden Bestellung bei preigu, denn der Kunde und seine Zufriedenheit stehen an erster Stelle. preigu setzt daher auf einen kompetenten Kundenservice, funktionierende Prozesse und schnelle Reaktion.

Spécialité

Bücher, Spielwaren

Profil professionnel du vendeur

preigu GmbH & Co. KG

Lengericher Landstraße 19
Osnabrück, Allemagne 49078

Contacter le vendeurConsulter les articles de ce vendeurAfficher la vitrine du vendeur

Conditions de vente

About Us

Legal website operator identification:

preigu GmbH & Co. KG
Lengericher Landstr. 19
49078 Osnabrück
Germany

Telephone: +49 (0) 541 / 580 72 84
Email: mail@preigu.de

VAT No: DE 455 380 498
AG Osnabrück - HRA 209647

PhG: preigu Verwaltung GmbH
AG Osnabrück - HRB 221793
CEO: Ansas Meyer

We are neither willing nor obliged to participate in dispute resolution proceedings before consumer arbitration boards.

We are a member of the initiative "FairCommerce" since 30.11.2016.
For more information, see: https://www.haendlerbund.de/de/haendlerbund/interessenvertretung/faircommerce

Droit de rétractation

Instructions for revocation

Right of withdrawal for the sale of goods

Revocation right for consumers
(A ‘consumer' is any natural person who concludes a legal transaction which, to an overwhelming extent, cannot be attributed to either his commercial or independent professional activities.)

Instructions for revocation

Revocation right
You have the right to revoke this contract within 14 days without specifying any reasons.
The revocation period is 14 days with effect from the day,

on which you or a third party nominated by you, which is not the carrier, had taken possession of the products, provided you had ordered one or more products within the scope of a standard order and this/these product/products is/are delivered uniformly;
on which you or a third party nominated by you, which is not the carrier, had taken possession of the last product, provided you had ordered several products within the scope of a standard order and these products are delivered separately;
on which you or a third party nominated by you, which is not the carrier, had taken possession of the last part delivery or the last unit, provided you had ordered a product, which is delivered in several part deliveries or units;

To exercise your right of withdrawal, you must inform us (preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, Telephone number: +49 (0) 541 / 580 72 84, E-Mail address: mail@preigu.de) by means of a clear declaration (e.g. a letter sent by post, or an e-mail) of your decision to withdraw from this contract. You can use the attached model withdrawal form for this purpose, which is, however, not mandatory.

You can also exercise your right of withdrawal online by clicking on a button labelled accordingly (such as ‘Withdraw from contract' or similar) on the AbeBooks/ZVAB website. If you use this online function, you will immediately receive a confirmation of receipt on a durable medium (e.g. via email) containing information on the content of the withdrawal notice, as well as the date and time of its receipt.

In order to safeguard the revocation period, it is sufficient that you send the notification about the exercise of the revocation right before the expiry of the revocation period.

Consequences of the revocation

If you revoke this contract, we shall repay all the payments, which we received from you, including the delivery costs (with the exception of additional costs, which arise from that fact that you selected a form of delivery other than the most reasonable standard delivery offered by us), immediately and at the latest within 14 days from the day on which we received the notification about the revocation of this contract from you. We use the same means of payment, which you had originally used during the original transaction, for this repayment unless expressly agreed otherwise with you; you will not be charged any fees owing to this repayment.

We can refuse the repayment until the products are returned to us or until you have furnished evidence that you have sent the products back to us, depending on whichever is earlier.

You must return or transfer the products to us immediately and, in any case, at the latest within 14 days with effect from the day on which you inform us of the revocation of this contract. The deadline is maintained if you send the products before the expiry of the 14 day deadline.

You bear the direct costs for returning the products.

You must pay for any depreciation of the products only if this depreciation can be attributed to any handling with you that was not necessary for checking the condition, features and functionality of the products.

Criteria for exclusion or expiry

The revocation right is not available for contracts

for delivery of products, which are not prefabricated and for whose manufacturing an individual selection or stipulation by the consumer is important or which are clearly tailored to the personal requirements of the consumer;
for delivery of products, which can spoil quickly or whose use-by date would be exceeded quickly;
for delivery of alcoholic drinks, whose price was agreed at the time of concluding the contract, which however can be delivered 30 days after the conclusion of the contract at the earliest and whose current value depends on the fluctuations in the market, on which the entrepreneur has no influence;
for delivery of newspapers, periodicals or magazines with the exception of subscription contracts. The revocation right expires prematurely in case of contracts
for delivery of sealed products, which are not suitable for return for reasons of health protection or hygiene if their seal has been removed after the delivery;
for delivery of products if they have been mixed inseparably with other goods after the delivery, owing to their condition;
for delivery of sound or video recording or computer software in a sealed package if the seal has been removed after the delivery.

Specimen - revocation form

(If you wish to revoke the contract, please fill up this form and send it back to us.)

To preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, Email address: mail@preigu.de :
I/we () herewith revoke the contract concluded by me/ us () regarding the purchase of the following products ()/
the provision of the following service ()
Ordered on ()/ received on ()
Name of the consumer(s)
Address of the consumer(s)
Signature of the consumer(s) (only in case of a notification on paper)
Date

(*) Cross out the incorrect option.

Advances in Management of Pediatric Brain Tumors

Item description from seller

Détails bibliographiques

Synopsis

A propos de ce titre

À propos de l’auteur